Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2019-04-25 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a senior management personnel (Vice General Manager) at the company. It includes details about the individual's background and confirms compliance with relevant regulations. There is no financial data, no report attached or referenced, and no mention of voting results or other categories. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in senior management.
2019-04-25 Chinese
2019年第一季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (317 characters) stating that the full 2019 first quarter report has been disclosed on the official exchange website. It does not contain the actual financial data or report content but directs investors to the full report. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA), not the report itself.
2019-04-25 Chinese
2019年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 First Quarter Report" of 迪瑞医疗科技股份有限公司, indicating it is a quarterly financial report. It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow analysis, and management discussion of financial data and business outlook. The length is substantial (15,000 characters) and includes actual financial data and analysis, not just an announcement or summary. The presence of quarterly period data and comprehensive financial disclosures aligns with the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-25 Chinese
第三届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from the company Di Rui Medical Technology Co., Ltd. It reports the approval of the 2019 first quarter report and the appointment of a deputy general manager. The document is short (744 characters) and does not contain the actual financial data of the quarterly report but refers readers to the full report on an external website. This indicates it is an announcement of board decisions rather than the report itself. Therefore, it fits best under Board/Management Information (MANG) as it includes management appointment and board resolutions.
2019-04-25 Chinese
独立董事关于第三届董事会第十二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion regarding the appointment of a senior management member at the company's board meeting. It references compliance with company law and stock exchange listing rules, and it is signed by independent directors. The content focuses on management appointment and related governance matters rather than financial results, audit, or shareholder voting outcomes. The document length is short (720 characters), and it is a formal opinion related to board/management changes. Therefore, it fits best under Board/Management Information (MANG).
2019-04-25 Chinese
2018年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2018 Annual Report Summary" of 迪瑞医疗科技股份有限公司 (Dirui Medical Technology Co., Ltd.). It contains detailed financial data for the year 2018, including revenue, net profit, earnings per share, and other key financial indicators. It also discusses business operations, market conditions, R&D activities, corporate governance, and shareholder information. The document references the full annual report and includes comprehensive financial and operational information typical of an annual report. The length of the document (11,199 characters) and the depth of financial and business analysis confirm it is the report itself, not just an announcement or summary notice. Therefore, the document fits the definition of an Annual Report (10-K). FY 2018
2019-04-19 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.